ImpriMed
ImpriMed is a company that creates individualized drug response prediction technology to help veterinarians fight lymphoma. The company's technology provides precision medicine techniques that allow veterinary oncologists to find appropriate anticancer drugs by developing a patient-derived database for pet cancer treatment that can eventuallybe translated into human cancer care, allowing doctors to decide on a final treatment regimen based on a data-driven prediction of response success in each individual patient's body.
Biotechnology Medical Veterinary
Funding Amount: $23M
Funding Type: Series A
Funding Date: 2023-12-19
City & State: Mountain View, California
Country United States
Employee Count: 33
Similar Startups
Rad AI
Rad AI develops an artificial intelligence automated report generation platform to automate repetitive tasks for radiologists. Its platform integrates with existing workflow, automating repetitive tasks, and enabling radiologists to improve radiology workflow that maximizes efficiency and accuracy while reducing burnout for radiologists andimproving patient care.
Yoneda Labs
Yoneda Labs helps to figure out the reaction parameters such as temperature, concentration, and catalyst during the process of making a drug or a material, enabling businesses to speed up the process of chemical laboratories.
DeepCure
DeepCure builds an AI engine for small-molecule drug discovery. The company is utilizing AI-driven drug discovery to expedite the advancement of groundbreaking, first-in-class precision therapeutics targeting areas with unmet medical needs.
Reshape
Reshape combines flexible robotics and machine learning and offers technology that is developed in a way that every machine performs a different task in the labs and does not create an overload on any single multitasking robot, enabling researchers and engineers to have access to automation alternatives that permit them to spend their time efficiently.